1.
Marson J, Lebwohl M. Apremilast as an Off-Label Therapeutic Agent: A Comprehensive Review of Safety and Efficacy Data in the Literature for Combination Therapy and Inflammatory Dermatoses. J of Skin [Internet]. 2021May21 [cited 2022Jan.25];5(3):203-27. Available from: https://www.jofskin.org/index.php/skin/article/view/1239